Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma	Recruiting	Phase 1 / Phase 2	2026-09-08		NCT04577014

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Incyte Corporation	153
Memorial Sloan Kettering Cancer Center	753

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Memorial Sloan Kettering Cancer Center	New York	United States	1000

Clinical trials